Should We Change the Target of Therapy in Pulmonary Hypertension?

Karyofyllis, Panagiotis; Demerouti, Eftychia; Habibis, Pavlos; Apostolopoulou, Styliani; Tsetika, Eleftheria-Garyfallia; Tsiapras, Dimitrios.

Afiliação

Karyofyllis P; Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.
Demerouti E; Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.
Habibis P; School of Medicine, University of Thessaly, 41221 Larissa, Greece.
Apostolopoulou S; School of Medicine, University of Thessaly, 41221 Larissa, Greece.
Tsetika EG; Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.
Tsiapras D; Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.

Life (Basel) ; 13(5)2023 May 17.

Article em En | MEDLINE | ID: mdl-37240847

Palavras-chave

balloon pulmonary angioplasty; chronic thromboembolic pulmonary hypertension; epoprostenol; mean pulmonary arterial pressure; pulmonary arterial hypertension; right ventricle; survival

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article